Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The nuclear receptors CAR and PXR activate hepatic genes in response to therapeutic drugs and xenobiotics, leading to the induction of drug-metabolizing enzymes, such as cytochrome P450. Insulin inhibits the ability of FOXO1 to express genes encoding gluconeogenic enzymes. Induction by drugs is known to be decreased by insulin, whereas gluconeogenic activity is often repressed by treatment with certain drugs, such as phenobarbital (PB). Performing cell-based transfection assays with drug-responsive and insulin-responsive enhancers, glutathione S-transferase pull down, RNA interference (RNAi), and mouse primary hepatocytes, we examined the molecular mechanism by which nuclear receptors and FOXO1 could coordinately regulate both enzyme pathways. FOXO1 was found to be a coactivator to CAR- and PXR-mediated transcription. In contrast, CAR and PXR, acting as corepressors, downregulated FOXO1-mediated transcription in the presence of their activators, such as 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) and pregnenolone 16alpha-carbonitrile, respectively. A constitutively active mutant of the insulin-responsive protein kinase Akt, but not the kinase-negative mutant, effectively blocked FOXO1 activity in cell-based assays. Thus, insulin could repress the receptors by activating the Akt-FOXO1 signal, whereas drugs could interfere with FOXO1-mediated transcription by activating CAR and/or PXR. Treatment with TCPOBOP or PB decreased the levels of phosphoenolpyruvate carboxykinase 1 mRNA in mice but not in Car(-/-) mice. We conclude that FOXO1 and the nuclear receptors reciprocally coregulate their target genes, modulating both drug metabolism and gluconeogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 2×
“A forkhead transcription factor, FOXO1, is an activator of gluconeogenic genes, such as PEPCK1, G6P, and insulin-like growth factor-binding protein 1 (29, 32 , 38, 57).”
BackgroundBiggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Seoane, J., Le, H.-V., Shen, L., Anderson, S. A., & Massagué, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00298-3 · Cited by 1,028
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
Self-citationThe Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Self-citationThe nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654 · cited 8×
“The CAR and PXR response elements, such as PBREM and XREM, are conserved in many human genes, such as CYP2B6 (47), CYP3A4 (5), and UGT1A1 (45).”
BackgroundInfluentialMaglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Goodwin, B., Hodgson, E., & Liddle, C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12400-5 · Cited by 646
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene
Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., & Negishi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6318 · Cited by 549
Self-citationGuo, S., Rena, G., Cichy, S., He, X., Cohen, P., & Unterman, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17184 · Cited by 540
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 535
Regulation of cytochrome P450 (CYP) genes by nuclear receptors
Honkakoski, P., & Negishi, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470321 · Cited by 501
Self-citationNakae, J., Park, B.-C., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 470
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 470
Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 466
Self-citationSugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.-H., Owens, I. S., Negishi, M., & Sueyoshi, T. (2001) · Hepatology · doi:10.1053/jhep.2001.24172 · Cited by 381
Self-citationFOXO Proteins Regulate Tumor Necrosis Factor-related Apoptosis Inducing Ligand Expression
Modur, V., Nagarajan, R., Evers, B. M., & Milbrandt, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207509200 · Cited by 371
Phenobarbital Response Elements of Cytochrome P450 Genes and Nuclear Receptors
Sueyoshi, T., & Negishi, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.123 · Cited by 362
Self-citationSchmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003616200 · Cited by 349
Regulation of CYP3A Gene Transcription by the Pregnane X Receptor
Goodwin, B., Redinbo, M. R., & Kliewer, S. A. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.111901.111051 · Cited by 327
Phosphorylation of Serine 256 Suppresses Transactivation by FKHR (FOXO1) by Multiple Mechanisms
Zhang, X., Gan, L., Pan, H., Guo, S., He, X., Olson, S. T., Mesecar, A., Adam, S., & Unterman, T. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208063200 · Cited by 294
Rena, G., Prescott, A. R., Guo, S., Cohen, P., & Unterman, T. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540605 · Cited by 261
Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways
Dowell, P., Otto, T. C., Adi, S., & Lane, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309069200 · Cited by 233
Rosenfeld, J. M., Vargas, R., Xie, W., & Evans, R. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0421 · Cited by 223
Wang, H., Faucette, S., Sueyoshi, T., Moore, R., Ferguson, S., Negishi, M., & LeCluyse, E. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212482200 · Cited by 215
Self-citationOrphan Nuclear Receptors: The Exotics of Xenobiotics
Xie, W., & Evans, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100033200 · Cited by 210 · cited 14×
“The CAR and PXR response elements, such as PBREM and XREM, are conserved in many human genes, such as CYP2B6 (47), CYP3A4 (5), and UGT1A1 (45).”
BackgroundInfluentialKobayashi, K., Sueyoshi, T., Inoue, K., Moore, R., & Negishi, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1069 · Cited by 190
Self-citationKawamoto, T., Kakizaki, S., Yoshinari, K., & Negishi, M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0547 · Cited by 168
Self-citationHonkakoski, P., Moore, R., Washburn, K. A., & Negishi, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.597 · Cited by 162
Self-citationZhao, H. H., Herrera, R. E., Coronado, E. B., Yang, M., Ludes-Meyers, J. H., Seybold-Tilson, K. J., Nawaz, Z., Yee, D., Barr, F. G., Diab, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104278200 · Cited by 162
Schuur, E. R., Loktev, A. V., Sharma, M., Sun, Z., Roth, R. A., & Weigel, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105555200 · Cited by 160
Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G., & Bai, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.104-118.2003 · Cited by 160
Yeagley, D., Guo, S., Unterman, T. G., & Quinn, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101215200 · Cited by 125
Insulin-induced phosphorylation on FKHR (Foxo1) targets to proteosomal degradation
Matsuzaki, H. (2003) · Medical Entomology and Zoology · Cited by 122
Orphan Receptor Promiscuity in the Induction of Cytochromes P450 by Xenobiotics
Smirlis, D., Muangmoonchai, R., Edwards, M., Phillips, I. R., & Shephard, E. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005930200 · Cited by 119
Characterization of Phenobarbital-inducible Mouse Cyp2b10 Gene Transcription in Primary Hepatocytes
Honkakoski, P., Moore, R., Gynther, J., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9746 · Cited by 113
Suwanickul, A., Morris, S. L., & Powell, D. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85302-4 · Cited by 112
Hirota, K., Daitoku, H., Matsuzaki, H., Araya, N., Yamagata, K., Asada, S., Sugaya, T., & Fukamizu, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200553200 · Cited by 109
Shiraki, T., Sakai, N., Kanaya, E. N., & Jingami, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212859200 · Cited by 109
Enzyme Inducers Improve Insulin Sensitivity in Non-insulin-dependent Diabetic Subjects
Lahtela, J. T., Arranto, A. J., & Sotaniemi, E. A. (1985) · Diabetes · doi:10.2337/diab.34.9.911 · Cited by 92
Machida, S., Spangenburg, E. E., & Booth, F. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10339 · Cited by 92
Thummel, K. E., & Schenkman, J. B. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09941-9 · Cited by 88
Kooi, B. T. V., Streeper, R. S., Svitek, C. A., Oeser, J. K., Powell, D. R., & O’Brien, R. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212570200 · Cited by 84
Yamamoto, Y., Kawamoto, T., & Negishi, M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00456-3 · Cited by 71
Self-citationPathophysiological Factors Affecting CAR Gene Expression
Pascussi, J., Dvořák, Z., Gerbal‐Chaloin, S., Assénat, E., Maurel, P., & Vilarem, M. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026394 · Cited by 67
Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR
Kakizaki, S., Yamamoto, Y., Ueda, A., Moore, R., Sueyoshi, T., & Negishi, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00482-8 · Cited by 66
Self-citationSakuma, T., Honma, R., Maguchi, S., Tamaki, H., & Nemoto, N. (2001) · Xenobiotica · doi:10.1080/00498250110046451 · Cited by 63
Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital
Argaud, D., Halimi, S., Catelloni, F., & Leverve, X. M. (1991) · Biochemical Journal · doi:10.1042/bj2800663 · Cited by 48
Sotaniemi, E. A., Pelkonen, O., Arranto, A. J., Tapanainen, P. J., Rautio, A., & Pasanen, M. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900308.x · Cited by 42
Kawamura, A., Yoshida, Y., Kimura, N., Oda, H., & Kakinuma, A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1544 · Cited by 38
Schmoll, D., Grempler, R., Unterman, T. G., & Walther, R. (2001) · Biochemical Society Transactions · doi:10.1042/bst029a069a · Cited by 15
Cited by
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“It was reported that phenobarbital decreased the expression of PEPCK and G6Pase in both primary hepatocytes and mouse liver, suggesting that phenobarbital may inhibit hepatic gluconeogenesis (Kodama et al., 2004; Miao et al., 2006).”
BackgroundEndocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Metadata
- Authors
- Kodama, S., Koike, C., Negishi, M., & Yamamoto, Y.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-09-01
- Volume
- 24
- Issue
- 18
- Pages
- 7931-7940
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2149038504
- Cited by
- 334
- References
- 57
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.